Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Amino acids have been explored as adjunctive treatments in addiction, including tobacco smoking and chewing, with some scientific rationale but limited robust clinical evidence. The basis for their use lies in the understanding that addiction alters neurotransmitter levels in the brain, notably dopamine, serotonin, and GABA. Amino acids such as L-tyrosine (a precursor to dopamine) and L-tryptophan (a precursor to serotonin) are sometimes used with the aim of restoring neurotransmitter balance during withdrawal and recovery. Small clinical trials and observational studies have suggested that certain amino acids may help reduce cravings and withdrawal symptoms. For example, N-acetylcysteine (NAC), an amino acid derivative, has shown some promise in reducing cravings in substance use disorders, including nicotine, though the effect sizes have generally been modest and not always consistent across studies.

Despite these theoretical and preliminary clinical findings, the overall quality of evidence remains low, with most studies being small, short-term, and sometimes lacking rigorous controls. No major clinical guidelines recommend amino acids as a primary therapy for tobacco addiction. Thus, while the scientific rationale exists and some early evidence is encouraging, more high-quality, large-scale research is needed. Currently, amino acids may be considered as experimental adjuncts rather than established treatments for tobacco addiction.

More about amino acids
More about Addictions (tobacco smoking or chewing)

Other ingredients used for Addictions (tobacco smoking or chewing)

Other health conditions supported by amino acids

Products containing amino acids

Nature's Sunshine AIVIA Whey Protein
Nature's Sunshine AIVIA Whey Protein
Nature's Sunshine Power Greens
Nature's Sunshine Power Greens To-Go